A1/A2 polymorphism of glycoprotein IIIa and association with excess procedural risk for coronary catheter interventions: a case-controlled study
- 1 February 1999
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 353 (9154) , 708-712
- https://doi.org/10.1016/s0140-6736(98)07257-2
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Final Results of the Balloon vs Optimal Atherectomy Trial (BOAT)Circulation, 1998
- Platelet glycoprotein Illa polymorphisms and risk of coronary stent thrombosisThe Lancet, 1997
- Association of the Platelet Pl A Polymorphism of Glycoprotein IIb/IIIa and the Fibrinogen Bβ 448 Polymorphism With Myocardial Infarction and Extent of Coronary Artery DiseaseCirculation, 1997
- Comparison of Coronary Bypass Surgery with Angioplasty in Patients with Multivessel DiseaseNew England Journal of Medicine, 1996
- A Polymorphism of a Platelet Glycoprotein Receptor as an Inherited Risk Factor for Coronary ThrombosisNew England Journal of Medicine, 1996
- A Randomized Comparison of Antiplatelet and Anticoagulant Therapy after the Placement of Coronary-Artery StentsNew England Journal of Medicine, 1996
- Heparin-Coated Palmaz-Schatz Stents in Human Coronary ArteriesCirculation, 1996
- A Randomized Trial Comparing Coronary Angioplasty with Coronary Bypass SurgeryNew England Journal of Medicine, 1994
- Guidelines for percutaneous transluminal coronary angioplasty. A report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty).Circulation, 1993
- Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature.Circulation, 1979